WO2003047656A1 - Verfahren und einrichtung zur überwachung der zufuhr von substitutionsflüssigkeit während einer extrakorporalen blutbehandlung - Google Patents
Verfahren und einrichtung zur überwachung der zufuhr von substitutionsflüssigkeit während einer extrakorporalen blutbehandlung Download PDFInfo
- Publication number
- WO2003047656A1 WO2003047656A1 PCT/EP2002/013115 EP0213115W WO03047656A1 WO 2003047656 A1 WO2003047656 A1 WO 2003047656A1 EP 0213115 W EP0213115 W EP 0213115W WO 03047656 A1 WO03047656 A1 WO 03047656A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pressure
- monitoring
- amplitude
- filter
- dialyzer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3639—Blood pressure control, pressure transducers specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3424—Substitution fluid path
- A61M1/3431—Substitution fluid path upstream of the filter
- A61M1/3434—Substitution fluid path upstream of the filter with pre-dilution and post-dilution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3424—Substitution fluid path
- A61M1/3437—Substitution fluid path downstream of the filter, e.g. post-dilution with filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3455—Substitution fluids
- A61M1/3465—Substitution fluids using dialysate as substitution fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3656—Monitoring patency or flow at connection sites; Detecting disconnections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M5/16854—Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
- A61M5/16859—Evaluation of pressure response, e.g. to an applied pulse
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S210/00—Liquid purification or separation
- Y10S210/929—Hemoultrafiltrate volume measurement or control processes
Definitions
- the invention relates to a method for monitoring the supply of substitution fluid during an extracorporeal blood treatment. Furthermore, the invention relates to a device for extracorporeal blood treatment with a device for monitoring the supply of substitution fluid.
- Various procedures for extracorporeal blood treatment and purification are used in chronic kidney failure to remove urinary substances and to withdraw fluid.
- the patient's blood is cleaned outside the body in a dialyzer.
- the dialyzer has a blood chamber and a dialysis fluid chamber, which are separated by a semipermeable membrane.
- the patient's blood flows through the blood chamber.
- the dialysis fluid chamber is continuously flowed through by fresh dialysis fluid.
- hemodialysis While in hemodialysis (HD) the transport of small-molecule substances through the membrane is essentially determined by the concentration differences (diffusion) between the dialysis fluid and the blood, in hemoftrationltration (HF) substances dissolved in plasma water, in particular higher-molecular substances, are caused by a high one Liquid flow (convection) through the membrane of the dialyzer effectively removed.
- the dialyser acts as a filter during hemofiltration.
- a combination of both methods is hemodiafiltration (HDF).
- hemo (dia) filtration part of the serum withdrawn through the membrane is replaced by a sterile substitution fluid, which is supplied to the extracorporeal bloodstream either upstream of the dialyzer (predilution) or downstream of the dialyzer (postdilution).
- Devices for hemo (dia) filtration are known in which the dialysis liquid is produced online from fresh water and concentrates and the substitution liquid online from the dialysis liquid.
- the substitution fluid is supplied to the extracorporeal blood circuit from the fluid system of the machine via a substitution fluid line.
- the substitution fluid line leads to a connection point on the arterial blood line upstream of the dialyzer, while in post-dilution the substitution liquid line leads to a connection point on the venous blood line downstream of the dialyzer.
- the substitution fluid line has a connector with which it can be connected to either the venous or arterial blood line.
- a clamp or the like is provided on the substitution fluid line to interrupt the fluid supply.
- the correct connection of the substitution fluid line is routinely checked in the known haemo (dia) filtration devices at the beginning of the blood treatment.
- the line leading to the dialysis fluid chamber and departing from the dialysis fluid chamber of the dialyzer and the venous blood line downstream of the connection point for the substitution fluid line are clamped off by means of hose clamps.
- the arterial blood line is already interrupted by the stationary blood pump upstream of the connection point for the substitution fluid line.
- the substituate pump for promoting the substitution fluid is then started up and the pressure in the venous blood line is measured by means of a venous pressure sensor. In the event that the substituate pump cannot build up a pressure in the venous blood line which is greater than a predetermined limit value, it is concluded that the connection of the substitution fluid line is incorrect, ie the supply of liquid is interrupted.
- the substituate pump for conveying the substitution fluid is a pump generating pressure waves, in particular a volumetric occlusion pump (roller pump).
- the pressure waves emanating from the substituate pump can propagate via the fluid system of the extracorporeal blood treatment device through the dialyzer into the extracorporeal blood circuit. This path is open even when the substitution fluid supply is interrupted. Then the substituate pump works against the closure. This increases the amplitude of the pressure waves that can be detected in the extracorporeal blood circulation.
- the amplitude of the pressure waves in the extracorporeal blood circuit downstream of the dialyzer or filter is measured. This has the advantage that a pressure sensor can be used, which is already provided in the venous blood line in the known blood treatment devices.
- the amplitude of the pressure waves in the liquid system is measured upstream of the dialyzer or filter. This has the advantage that monitoring is also possible when the
- Blood treatment device is possible as a hemofiltration device, in which the pressure waves cannot reach the extracorporeal circuit, since the inlet of the dialyzer or filter is separated from the dialysis fluid supply.
- the pressure signal is preferably filtered with a bandpass filter in order to eliminate interference pulses, the amplitude of the filtered pressure signal then being compared with the predetermined limit value.
- An acoustic and / or visual alarm is expediently given when the predetermined limit value is exceeded. However, it is also possible to intervene in the control of the blood treatment device.
- the monitoring device of the extracorporeal blood treatment device has means for monitoring the amplitude of the pressure waves of the substituate pump in the liquid system, preferably upstream of the dialystor or filter or in the extracorporeal blood circuit, preferably downstream of the dialyzer or filter, and means for evaluating the pressure wave amplitude.
- the substituate pump generating pressure waves is arranged in the substitution fluid line, which leads from the fluid system to the bloodstream upstream or downstream of the dialyzer or filter.
- the substitution fluid line can be a single hose line or a hose line system with several branches.
- the substitution fluid line can be connected directly to the venous or arterial blood line.
- the line it is also possible for the line to be connected to drip chambers or the like which are provided in the venous or arterial blood line.
- the fluid system of the blood treatment device can comprise a dialysis fluid supply line leading to the dialysis fluid chamber of the dialyzer and a dialysis fluid discharge line leading away from the dialysis fluid chamber of the dialyzer.
- One or more filters can be arranged in the liquid system to increase safety. Further lines, for example bypass lines, etc., can also be provided.
- the only decisive factor is that the fluid system allows pressure waves to propagate; H. is a system completely filled with a medium.
- Figure 1 shows a device for extracorporeal blood treatment with a
- Figure 2 shows the filtered venous pressure signal as a function of time
- FIG. 1 shows a simplified schematic illustration of the essential components of a hemo (dia) filtration device together with a device for monitoring the supply of substitution fluid from the fluid system of the hamo (dia) filtration device into the extracorporeal blood circuit.
- the hemo (dia) filtration device has a dialyzer or filter 1, which is separated by a membrane 2 into a first chamber 3 through which blood flows and a second chamber 4 through which dialysis fluid flows.
- the first chamber 3 is connected to an extracorporeal blood circuit 5 A, while the second chamber 4 is connected to the liquid system 5B of the hemo (dia) filtration device.
- the extracorporeal blood circuit 5 A comprises an arterial blood line 6, which leads to the inlet 3a of the blood chamber 3, and a venous blood line 7, which extends from the outlet 3b of the blood chamber 3 of the dialyzer 1.
- an arterial drip chamber 8 is connected in the arterial blood line 6 and a venous drip chamber 9 in the venous blood line 7.
- the patient's blood is conveyed through the blood chamber of the dialyzer by means of an arterial blood pump 10, in particular a roller pump, which is arranged on the arterial blood line 6.
- the fluid system 5B comprises a dialysis fluid supply line 11, which leads to the inlet 4a of the dialysis fluid chamber 4, and a dialysis fluid discharge line 12, which leads from the outlet 4b of the dialysis fluid chamber 4 of the dialyzer 1.
- Fresh dialysis fluid flows from a dialysis fluid source, not shown, into the dialysis fluid chamber via the dialysis fluid supply line 11. while the used dialysis fluid is discharged from the dialysis fluid chamber via the dialysis fluid discharge line 12 to a drain (not shown).
- the balancing device generally provided in the haemo (dia) filtration devices for balancing fresh dialysis fluid against used dialysis fluid is not shown for the sake of clarity. Additional devices for cleaning and flushing the system are also not shown.
- the dialysis fluid supply line 11 comprises a first section 11a leading to the inlet 13a of a first chamber 13 of a sterile filter 16 divided by a membrane 14 into the first chamber and a second chamber 15, and a second section 11b which extends from the outlet 13b of the first Chamber 13 of the filter 16 goes out and leads to the inlet 4a of the dialysis fluid chamber 4.
- dialysis fluid can be supplied from the fluid system 5B as a substitution fluid via the hose line 17 to the extracorporeal blood circuit 5A.
- the substitution liquid line 17 has two line sections 17a, 17b, 17c, 17d at both ends.
- the line section 17a is connected to a first outlet 15a and the line section 17b to a second outlet 15b of the second chamber 15 of the sterile filter 16, while a connector 18a, 18b is connected to each of the line sections 17c and 17d.
- the substitution fluid line 17 is connected to a connection line 19 leading to the arterial drip chamber 8 and a connection line 20 leading to the venous drip chamber 9.
- the connecting lines 19, 20 have corresponding connecting pieces 19a, 20a.
- Hose clamps 35, 36 are provided on the line sections 17c and 17d, by means of which a liquid connection can optionally be made to the connecting line 19 or 20 in order to carry out a pre- or post-dilution.
- a branch can also be dispensed with if one for disconnecting the substitution fluid line 17 downstream of the substituate pump 22 Hose clamp is provided. But then it is necessary to manually replace the line connections.
- the substitution fluid is conveyed by means of an occlusion pump, in particular roller pump 22, into which the substitution fluid line 17 is inserted.
- roller pumps are part of the prior art. They have several rollers 22a, 22b with which the cross section of the hose line for conveying the liquid is reduced. This creates pressure waves that can propagate in both directions via the substitution fluid line.
- a Hall sensor 23 is provided on the substituate pump 22 and measures the pump rate.
- a pressure sensor 24 is provided, which is connected to the venous drip chamber 9 via a pressure line 25.
- the pressure sensor supplies an electrical signal proportional to the pressure in the venous blood line.
- the hose clamps 35, 36 are closed so that dialysis fluid flows through the dialysis fluid chamber 4 of the dialyzer.
- the hose clamp 35, 36 is opened so that sterile dialysis fluid 16 flows out of the sterile filter as a substitution fluid into the venous drip chamber 8 (predilution) or arterial drip chamber 9 (postdilution). But it is also an operation of the hemo (dia) filtration device only as
- a shut-off device 26 is provided upstream of the dialyzer 1.
- the venous pressure sensor 24 is connected to a signal line 28 with a bandpass filter 29.
- the bandpass filter 29 is in turn connected to a data line 30 an evaluation unit 31 which receives an electrical signal dependent on the pumping rate of the substituate pump 22 via a further signal line 34 from the Hall sensor 23.
- the evaluation unit 31 determines the amplitude of the pressure signal filtered with the bandpass filter 29 and compares the amplitude with a predetermined limit value.
- the predetermined limit value is assumed to be 1.5 to 2.5 times, preferably 1.8 to 2.2 times, in particular 2.0 times, the amplitude of the pressure waves measured during trouble-free operation.
- FIGS. 2A, 2B and 2C show the filtered venous pressure signal together with the periodic signal from the Hall sensor as a function of time at a submersible pump rate of 20 ml / min for the cases of postdilution (A), disconnection (B) and predilution (C ). Blood and dialysate flow are set to 300 ml / min. The following values result:
- FIGS. 3A, 3B and 3C show the filtered venous pressure signal and the Hall signal as a function of time at a higher pumping rate of 60 ml / min with postdilution (A), disconnection (B) and predilution (C). Blood and dialysate flow are again 300 ml / min. The following values result:
- the evaluation unit 31 also receives the signal from the Hall sensor 23.
- the evaluation unit assumes that an increase in the pressure amplitude is a result of an interruption of the substitution liquid inflow. For example, the limit value amplitude after / amplitude before > 1.5 can be assumed.
- the threshold value must be corrected accordingly for higher pumping rates. This can be done take place that different threshold values are assumed for different pump rate ranges.
- the increase in pressure amplitude is due to the following. If the flow of substitution fluid is blocked, the spring forces of the rotor of the roller pump 22 are no longer able to compress the substitution fluid hose 17, so that the maximum system pressure is reached. This pressure, which is also known as the occlusion pressure, is significantly higher than the normal system pressure. The rotor thus promotes a blockage of substitution fluid against the higher occlusion pressure. Because of the closed hose clamp 35 or 36, the transmission path of the pressure waves via the substitution fluid hose 17 to the venous pressure sensor 24 is completely blocked.
- the pressure waves generated by the substituate pump 22 reach the venous pressure sensor 24 via the sterile filter 16, the second section 11b of the dialysis fluid supply line, the dialyzer 1, the venous blood line 7, the venous drip chamber 9 and finally the pressure line 25.
- the amplitude of the pressure signal when disconnected due to the increased occlusion pressure Like FIGS. 2 to 4 show, the amplitude of the pressure signal when disconnected due to the increased occlusion pressure.
- the pressure waves are not monitored in the extracorporeal blood circuit (5 A), but in the liquid system (5B) of the blood treatment device upstream of the dialyzer 1 or filter.
- This embodiment differs from the exemplary embodiment described above in that it is not the pressure sensor 24 in the venous blood line 7 but a pressure sensor 24 'is provided in the second section 11b of the dialysis fluid supply line.
- This pressure sensor 24 ' is indicated in FIG. 1 in dashed lines as an alternative embodiment. It is connected to the low-pass filter 29 via the signal line 28 ', also indicated in broken lines.
- the pressure waves can also be measured at another point in the liquid system.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002358528A AU2002358528A1 (en) | 2001-12-05 | 2002-11-22 | Method and device for monitoring the supply of substitution liquid during an extracorporeal blood treatment |
EP02792789A EP1450880B1 (de) | 2001-12-05 | 2002-11-22 | Einrichtung zur überwachung der zufuhr von substitutionsflüssigkeit während einer extrakorporalen blutbehandlung |
JP2003548909A JP4235556B2 (ja) | 2001-12-05 | 2002-11-22 | 体外血液処理時に置換液の供給をモニターするための方法および素子 |
US10/498,034 US7850856B2 (en) | 2001-12-05 | 2002-11-22 | Method and device for monitoring the supply of substitution fluid during an extracorporeal blood treatment |
DE50210524T DE50210524D1 (de) | 2001-12-05 | 2002-11-22 | Einrichtung zur überwachung der zufuhr von substitutionsflüssigkeit während einer extrakorporalen blutbehandlung |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10159620A DE10159620C1 (de) | 2001-12-05 | 2001-12-05 | Verfahren und Einrichtung zur Überwachung der Zufuhr von Substitutionsflüssigkeit während einer extrakorporalen Blutbehandlung |
DE10159620.0 | 2001-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003047656A1 true WO2003047656A1 (de) | 2003-06-12 |
Family
ID=7708056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/013115 WO2003047656A1 (de) | 2001-12-05 | 2002-11-22 | Verfahren und einrichtung zur überwachung der zufuhr von substitutionsflüssigkeit während einer extrakorporalen blutbehandlung |
Country Status (8)
Country | Link |
---|---|
US (1) | US7850856B2 (de) |
EP (1) | EP1450880B1 (de) |
JP (1) | JP4235556B2 (de) |
AT (1) | ATE367175T1 (de) |
AU (1) | AU2002358528A1 (de) |
DE (2) | DE10159620C1 (de) |
ES (1) | ES2287348T3 (de) |
WO (1) | WO2003047656A1 (de) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005324024A (ja) * | 2004-05-11 | 2005-11-24 | Fresenius Medical Care Deutschland Gmbh | 血液の体外循環処理中での置換液の供給を監視する方法および装置 |
WO2008053259A1 (en) | 2006-10-30 | 2008-05-08 | Gambro Lundia Ab | Hemo(dia)filtration apparatus |
WO2008135193A1 (de) | 2007-05-04 | 2008-11-13 | Fresenius Medical Care Deutschland Gmbh | Verfahren und vorrichtung zur überwachung einer blutbehandelungseinheit einer extrakorporalen blutbehandlungsvorrichtung |
WO2009056325A1 (de) * | 2007-11-03 | 2009-05-07 | Fresenius Medical Care Deutschland Gmbh | Verfahren und vorrichtung zur überwachung der zufuhr von substitutionsflüssigkeit während einer extrakorporalen blutbehandlung |
WO2009074588A1 (en) * | 2007-12-10 | 2009-06-18 | Sorin Group Italia S.R.L. | Unit for the infusion of a substitute solution by a dialysis machine |
JP2010234107A (ja) * | 2004-05-11 | 2010-10-21 | Fresenius Medical Care Deutschland Gmbh | 血液の体外循環処理中での置換液の供給を監視する方法および装置 |
US8647290B2 (en) | 2008-05-26 | 2014-02-11 | Gambro Lundia Ab | Hemodialysis or hemo(dia)filtration apparatus and a method for controlling a hemodialysis or hemo(dia)filtration apparatus |
US8715215B2 (en) | 2007-09-18 | 2014-05-06 | Fresenius Medical Care Deutschland Gmbh | Method for verifying and/or monitoring the correct function of a supply device |
US9211370B2 (en) | 2003-12-16 | 2015-12-15 | Baxter International Inc. | Renal therapy blood cleansing system with isolation feature |
US11376353B2 (en) | 2009-11-26 | 2022-07-05 | Fresenius Medical Care Deutschland Gmbh | Method for regulating the supply of substituate during extracorporeal blood treatment and extracorporeal blood treatment device comprising a unit for regulating the supply of substituate |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6852090B2 (en) | 1997-02-14 | 2005-02-08 | Nxstage Medical, Inc. | Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge |
US20040243047A1 (en) * | 1997-02-14 | 2004-12-02 | Brugger James M. | Single step fluid circuit engagement device and method |
US7780619B2 (en) * | 1999-11-29 | 2010-08-24 | Nxstage Medical, Inc. | Blood treatment apparatus |
US20050010158A1 (en) * | 2001-05-24 | 2005-01-13 | Brugger James M. | Drop-in blood treatment cartridge with filter |
US6649063B2 (en) | 2001-07-12 | 2003-11-18 | Nxstage Medical, Inc. | Method for performing renal replacement therapy including producing sterile replacement fluid in a renal replacement therapy unit |
US20030010717A1 (en) * | 2001-07-13 | 2003-01-16 | Nx Stage Medical, Inc. | Systems and methods for handling air and/or flushing fluids in a fluid circuit |
US8235931B2 (en) | 2003-01-15 | 2012-08-07 | Nxstage Medical, Inc. | Waste balancing for extracorporeal blood treatment systems |
WO2004066121A2 (en) * | 2003-01-15 | 2004-08-05 | Nxstage Medical Inc. | Waste balancing for extracorporeal blood treatment systems |
US7470265B2 (en) * | 2003-03-20 | 2008-12-30 | Nxstage Medical, Inc. | Dual access spike for infusate bags |
US8029454B2 (en) | 2003-11-05 | 2011-10-04 | Baxter International Inc. | High convection home hemodialysis/hemofiltration and sorbent system |
WO2006049822A1 (en) * | 2004-10-28 | 2006-05-11 | Nxstage Medical, Inc | Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit |
US20070102340A1 (en) * | 2005-10-27 | 2007-05-10 | Nxstage Medical, Inc. | Blood treatment filter and method of manufacturing |
DE102006032815A1 (de) * | 2006-07-14 | 2008-01-17 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtung zur Überwachung eines extrakorporalen Blutkreislaufs |
EP2091592B1 (de) * | 2006-10-30 | 2014-05-07 | Gambro Lundia AB | Extrakorporale blutkammer |
EP2407191B1 (de) * | 2006-10-30 | 2012-12-12 | Gambro Lundia AB | Luftseparator für extrakorporale Flüssigkeitsbehandlungssets |
DE102007024463A1 (de) * | 2007-05-25 | 2008-11-27 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtung zur Überprüfung der korrekten Ankopplung einer Zugabevorrichtung an ein Therapiegerät |
DE102007056475A1 (de) * | 2007-11-22 | 2009-06-04 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtung zum Bestimmen der Rezirkulation in einer Fistel oder der kardiopulmonalen Rezirkulation sowie Blutbehandlungsvorrichtung mit einer Vorrichtung zur Bestimmung der Fistelrezirkulation oder des kardiopulmonalen Rezirkulationsanteils |
WO2009127683A1 (en) * | 2008-04-17 | 2009-10-22 | Gambro Lundia Ab | Method and devices for monitoring flow circuits |
WO2009131762A2 (en) * | 2008-04-22 | 2009-10-29 | Exxonmobil Upstream Research Company | Functional-based knowledge analysis in a 2d and 3d visual environment |
DE102008051541B4 (de) * | 2008-10-14 | 2010-09-09 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtung zur Überprüfung der Zufuhr von Substitutionsflüssigkeit stromauf oder stromab eines Dialysators oder Filters einer extrakorporalen Blutbehandlungsvorrichtung |
DE102008061122A1 (de) * | 2008-12-09 | 2010-06-17 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtung zum Ermitteln und/oder Überwachen eines körperlichen Zustandes, insbesondere einer kardiovaskulären Größe, eines Patienten basierend auf einer Amplitude eines Drucksignals |
EP3689392B1 (de) | 2009-04-23 | 2024-03-20 | Fresenius Medical Care Deutschland GmbH | Behandlungsvorrichtung zum entfernen von blut aus einem extrakorporalen blutkreislauf |
JP5548001B2 (ja) * | 2010-03-25 | 2014-07-16 | 日機装株式会社 | 血液浄化装置 |
JP6038906B2 (ja) | 2011-06-23 | 2016-12-07 | ガンブロ・ルンディア・エービーGambro Lundia Ab | 体外血液処理の血液経路中断を検出すること |
DE102012004970A1 (de) * | 2012-03-14 | 2013-09-19 | Fresenius Medical Care Deutschland Gmbh | Verfahren zum Dosieren eines mittels einer Blutbehandlungsvorrichtung erzeugten Substituats sowie Vorrichtungen |
DE102012008551B4 (de) * | 2012-04-30 | 2017-09-07 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung zur Durchführung eines Verfahrens zur Konservierung einer Blutbehandlungsvorrichtung sowie Verfahren zur Konservierung einer Blutbehandlungsvorrichtung |
US10137233B2 (en) | 2012-12-18 | 2018-11-27 | Gambro Lundia Ab | Detecting pressure pulses in a blood processing apparatus |
DE102014102731A1 (de) * | 2014-02-28 | 2015-09-03 | B. Braun Avitum Ag | Vorrichtung und Verfahren zur Erkennung einer venösen Nadeldiskonnektion |
CN103830783B (zh) * | 2014-03-10 | 2016-01-13 | 北京工业大学 | 一种体外循环灌注决策系统 |
DE102014108227A1 (de) * | 2014-06-12 | 2015-12-17 | B. Braun Avitum Ag | Dialysemaschinen-integrierte Substitutionspumpe |
JP5822319B1 (ja) * | 2014-07-09 | 2015-11-24 | 日本ライフライン株式会社 | 持続的血液浄化用装置 |
DE102014010306A1 (de) | 2014-07-11 | 2016-01-14 | Fresenius Medical Care Deutschland Gmbh | Disposable und Vorrichtung für die extrakorporale Blutbehandlung sowie Verfahren zur Überprüfung einer korrekten Leitungsankopplung |
JP7227460B2 (ja) * | 2018-11-22 | 2023-02-22 | 澁谷工業株式会社 | 血液透析装置における補液通路の閉塞検出装置 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0189561A1 (de) * | 1984-12-07 | 1986-08-06 | Fresenius AG | Hämodiafiltrationsgerät |
US5366630A (en) * | 1991-08-14 | 1994-11-22 | Hospal Industrie | Artificial kidney and a method of controlling it |
EP0834329A1 (de) * | 1996-09-09 | 1998-04-08 | Kaneka Corporation | Verfahren und Vorrichtung zur Behandlung von Blut |
US5906589A (en) * | 1996-11-13 | 1999-05-25 | Cobe Laboratories, Inc. | Method and apparatus for occlusion monitoring using pressure waveform analysis |
US6090048A (en) * | 1995-09-12 | 2000-07-18 | Gambro Ab | Method and arrangement for detecting the condition of a blood vessel access |
EP1095666A1 (de) * | 1999-10-29 | 2001-05-02 | Infomed S.A. | Vorrichtung zur extrakorporalen Blutreinigung |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4148314A (en) * | 1976-10-18 | 1979-04-10 | Baxter Travenol Laboratories, Inc. | Blood pressure alarm system for dialysis machines |
US4710163A (en) * | 1986-06-06 | 1987-12-01 | Ivac Corporation | Detection of fluid flow faults in the parenteral administration of fluids |
US5190522A (en) * | 1989-01-20 | 1993-03-02 | Institute Of Biocybernetics And Biomedical Engineering P.A.S. | Device for monitoring the operation of a delivery system and the method of use thereof |
US5910252A (en) * | 1993-02-12 | 1999-06-08 | Cobe Laboratories, Inc. | Technique for extracorporeal treatment of blood |
DE19534417A1 (de) * | 1995-09-16 | 1997-03-20 | Fresenius Ag | Verfahren zum Überprüfen von mindestens einem im Dialysierflüssigkeitssystem einer Vorrichtung zur extrakorporalen Blutbehandlung angeordneten Filter |
DE19700466A1 (de) * | 1997-01-09 | 1998-07-16 | Polaschegg Hans Dietrich Dr | Einrichtung und Verfahren zur Hämodiafiltration |
SE510286C2 (sv) * | 1997-09-22 | 1999-05-10 | Gambro Med Tech Ab | Förfarande och anordning för övervakning av infusionspump i en hemo- eller hemodiafiltreringsmaskin |
US6824524B1 (en) * | 1999-03-02 | 2004-11-30 | Infomed Sa | Tubing for the extracorporal purification of the blood and use thereof |
WO2001095955A1 (fr) * | 2000-06-15 | 2001-12-20 | Jms Co., Ltd. | Dialyseur automatique et procede de dialyse |
US6585675B1 (en) * | 2000-11-02 | 2003-07-01 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
IL156918A0 (en) * | 2001-02-07 | 2004-02-08 | Nephros Inc | Method and apparatus for a hemodiafiltration delivery module |
EP1314442A1 (de) * | 2001-11-26 | 2003-05-28 | Infomed S.A. | Vorrichtung zur intra- und extrakorporalen Reinigung |
DE102004023080B4 (de) * | 2004-05-11 | 2009-01-15 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtung zur Überwachung der Zufuhr von Substitutionsflüssigkeit während einer extrakorporalen Blutbehandlung |
-
2001
- 2001-12-05 DE DE10159620A patent/DE10159620C1/de not_active Expired - Fee Related
-
2002
- 2002-11-22 JP JP2003548909A patent/JP4235556B2/ja not_active Expired - Lifetime
- 2002-11-22 DE DE50210524T patent/DE50210524D1/de not_active Expired - Lifetime
- 2002-11-22 AU AU2002358528A patent/AU2002358528A1/en not_active Abandoned
- 2002-11-22 ES ES02792789T patent/ES2287348T3/es not_active Expired - Lifetime
- 2002-11-22 EP EP02792789A patent/EP1450880B1/de not_active Expired - Lifetime
- 2002-11-22 US US10/498,034 patent/US7850856B2/en active Active
- 2002-11-22 AT AT02792789T patent/ATE367175T1/de not_active IP Right Cessation
- 2002-11-22 WO PCT/EP2002/013115 patent/WO2003047656A1/de active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0189561A1 (de) * | 1984-12-07 | 1986-08-06 | Fresenius AG | Hämodiafiltrationsgerät |
US5366630A (en) * | 1991-08-14 | 1994-11-22 | Hospal Industrie | Artificial kidney and a method of controlling it |
US6090048A (en) * | 1995-09-12 | 2000-07-18 | Gambro Ab | Method and arrangement for detecting the condition of a blood vessel access |
EP0834329A1 (de) * | 1996-09-09 | 1998-04-08 | Kaneka Corporation | Verfahren und Vorrichtung zur Behandlung von Blut |
US5906589A (en) * | 1996-11-13 | 1999-05-25 | Cobe Laboratories, Inc. | Method and apparatus for occlusion monitoring using pressure waveform analysis |
EP1095666A1 (de) * | 1999-10-29 | 2001-05-02 | Infomed S.A. | Vorrichtung zur extrakorporalen Blutreinigung |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11672897B2 (en) | 2003-12-16 | 2023-06-13 | Baxter International Inc. | Blood rinseback system and method |
EP1699505B2 (de) † | 2003-12-16 | 2022-08-03 | Baxter International Inc. | Medizinische flüssigkeitstherapie-flusskontrollsysteme |
US10426882B2 (en) | 2003-12-16 | 2019-10-01 | Baxter International Inc. | Blood rinseback system and method |
US10195332B2 (en) | 2003-12-16 | 2019-02-05 | Baxter International Inc. | Renal therapy blood cleansing system with selective valve feature |
US9211370B2 (en) | 2003-12-16 | 2015-12-15 | Baxter International Inc. | Renal therapy blood cleansing system with isolation feature |
JP2010234107A (ja) * | 2004-05-11 | 2010-10-21 | Fresenius Medical Care Deutschland Gmbh | 血液の体外循環処理中での置換液の供給を監視する方法および装置 |
JP4593354B2 (ja) * | 2004-05-11 | 2010-12-08 | フレゼニウス メディカル ケア ドイチラント ゲー・エム・ベー・ハー | 血液の体外循環処理中での置換液の供給を監視する方法および装置 |
JP2005324024A (ja) * | 2004-05-11 | 2005-11-24 | Fresenius Medical Care Deutschland Gmbh | 血液の体外循環処理中での置換液の供給を監視する方法および装置 |
US8708943B2 (en) | 2006-10-30 | 2014-04-29 | Gambro Lundia Ab | Hemo(dia) filtration apparatus |
WO2008053259A1 (en) | 2006-10-30 | 2008-05-08 | Gambro Lundia Ab | Hemo(dia)filtration apparatus |
US8574183B2 (en) | 2007-05-04 | 2013-11-05 | Fresenius Medical Care Deutschland Gmbh | Method and device for monitoring a blood treatment unit of an extracorporeal blood treatment device |
WO2008135193A1 (de) | 2007-05-04 | 2008-11-13 | Fresenius Medical Care Deutschland Gmbh | Verfahren und vorrichtung zur überwachung einer blutbehandelungseinheit einer extrakorporalen blutbehandlungsvorrichtung |
US8715215B2 (en) | 2007-09-18 | 2014-05-06 | Fresenius Medical Care Deutschland Gmbh | Method for verifying and/or monitoring the correct function of a supply device |
US8216478B2 (en) | 2007-11-03 | 2012-07-10 | Fresenius Medical Care Deutschland Gmbh | Method and apparatus for monitoring the supply of replacement fluid during an extracorporeal treatment of blood |
WO2009056325A1 (de) * | 2007-11-03 | 2009-05-07 | Fresenius Medical Care Deutschland Gmbh | Verfahren und vorrichtung zur überwachung der zufuhr von substitutionsflüssigkeit während einer extrakorporalen blutbehandlung |
WO2009074588A1 (en) * | 2007-12-10 | 2009-06-18 | Sorin Group Italia S.R.L. | Unit for the infusion of a substitute solution by a dialysis machine |
US8647290B2 (en) | 2008-05-26 | 2014-02-11 | Gambro Lundia Ab | Hemodialysis or hemo(dia)filtration apparatus and a method for controlling a hemodialysis or hemo(dia)filtration apparatus |
US11376353B2 (en) | 2009-11-26 | 2022-07-05 | Fresenius Medical Care Deutschland Gmbh | Method for regulating the supply of substituate during extracorporeal blood treatment and extracorporeal blood treatment device comprising a unit for regulating the supply of substituate |
Also Published As
Publication number | Publication date |
---|---|
US20050065459A1 (en) | 2005-03-24 |
EP1450880B1 (de) | 2007-07-18 |
EP1450880A1 (de) | 2004-09-01 |
ES2287348T3 (es) | 2007-12-16 |
US7850856B2 (en) | 2010-12-14 |
JP2005511151A (ja) | 2005-04-28 |
DE10159620C1 (de) | 2003-08-14 |
ATE367175T1 (de) | 2007-08-15 |
JP4235556B2 (ja) | 2009-03-11 |
AU2002358528A1 (en) | 2003-06-17 |
DE50210524D1 (de) | 2007-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10159620C1 (de) | Verfahren und Einrichtung zur Überwachung der Zufuhr von Substitutionsflüssigkeit während einer extrakorporalen Blutbehandlung | |
EP2108391B1 (de) | Verfahren und Vorrichtung zur Überwachung der Zufuhr von Substitutionsflüssigkeit während einer extrakorporalen Blutbehandlung | |
DE19757523C1 (de) | Verfahren zur Überwachung der Funktionsfähigkeit einer Teileinrichtung einer Blutbehandlungsvorrichtung und Blutbehandlungsvorrichtung mit einer Einrichtung zu einer solchen Überwachung | |
DE102008051541B4 (de) | Verfahren und Vorrichtung zur Überprüfung der Zufuhr von Substitutionsflüssigkeit stromauf oder stromab eines Dialysators oder Filters einer extrakorporalen Blutbehandlungsvorrichtung | |
EP2203198B1 (de) | Verfahren und vorrichtung zur überwachung der zufuhr von substitutionsflüssigkeit während einer extrakorporalen blutbehandlung | |
DE19940624C1 (de) | Sicherheitsvorrichtung für eine Blutbehandlungsvorrichtung und Verfahren zur Erhöhung der Sicherheit einer Blutbehandlungsvorrichtung | |
DE10218846C1 (de) | Verfahren zur Unterbrechung oder Fortführung einer extrakorporalen Blutbehandlung mit veränderten Flussraten und Vorrichtung zur extrakorporalen Blutbehandlung | |
DE10201109C1 (de) | Verfahren und Vorrichtung zur Detektion einer Leckage in einem Flüssigkeitssystem einer Blutbehandlungsvorrichtung | |
DE19734002C1 (de) | Verfahren zur Überwachung eines Gefäßzuganges während einer Dialysebehandlung und Vorrichtung zur Dialysebehandlung mit einer Einrichtung zur Überwachung eines Gefäßzuganges | |
EP0974371B1 (de) | Verfahren und Vorrichtung zum Überprüfen des ordnungsgemässen Austausches eines gebrauchten Filters in einer Vorrichtung zur extrakorporalen Blutbehandlung | |
DE19523505A1 (de) | Hämo(dia)filtrationsvorrichtung mit Filtratflußsteuerung | |
EP2432518B1 (de) | Vorrichtung und verfahren zur erkennung eines schlauchleitungssystems für eine extrakorporale blutbehandlungsvorrichtung | |
EP1687045A1 (de) | Verfahren und vorrichtung zum erkennen von störungen des blutflusses in einem extrakorporalen blutkreislauf | |
EP2931333B1 (de) | Vorrichtung und verfahren zum überwachen eines extrakorporalen blutkreislaufs zur erkennung von luftblasen | |
EP3445418B1 (de) | Medizinische behandlungsvorrichtung und verfahren zur überwachung einer medizinischen behandlungsvorrichtung | |
EP1348458B1 (de) | Verfahren und Vorrichtung zur Überwachung der Zufuhr von Substitutionsflüssigkeit während einer extrakorporalen Blutbehandlung | |
EP2736561B1 (de) | Verfahren sowie vorrichtungen zum ablösen von gasansammlungen von einem gerinnselfänger eines extrakorporalen blutkreislaufs | |
WO2019193090A1 (de) | Dialysevorrichtung zur durchführung einer dialysebehandlung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002792789 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003548909 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10498034 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2002792789 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002792789 Country of ref document: EP |